Auditory evoked potentials might have the potential to serve as early indicators related to amyloid beta peptide toxicity

Davies, 1987, A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with alzheimers-disease, J Neurol Sci, 78, 151, 10.1016/0022-510X(87)90057-8 Terry, 1991, Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment, Ann Neurol, 30, 572, 10.1002/ana.410300410 Sakono, 2010, Amyloid oligomers: formation and toxicity of A beta oligomers, FEBS J, 277, 1348, 10.1111/j.1742-4658.2010.07568.x Galasko, 2017, CSF biomarkers for Alzheimer disease - approaching consensus, Nat Rev Neurol, 13, 131, 10.1038/nrneurol.2017.11 Karran, 2011, The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics, Nat Rev Drug Discov, 10, 698, 10.1038/nrd3505 Palop, 2010, Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks, Nat Neurosci, 13, 812, 10.1038/nn.2583 Salloway, 2014, Phase 3 trials of solanezumab and bapineuzumab for alzheimer's disease REPLY, N Engl J Med, 370, 1460, 10.1056/NEJMoa1304839 Siemers, 2016, Phase 3 solanezumab trials: secondary outcomes in mild Alzheimer's disease patients, Alzheimers Dement, 12, 110, 10.1016/j.jalz.2015.06.1893 Vandenberghe, 2016, Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials, Alzheimer's Res Ther, 8, 10.1186/s13195-016-0189-7 Murphy, 2019, Olfactory and other sensory impairments in Alzheimer disease, Nat Rev Neurol, 15, 11, 10.1038/s41582-018-0097-5 Gonsalvez, 2017, Therapeutic noninvasive brain stimulation in alzheimer's disease, Curr Alzheimer Res, 14, 362, 10.2174/1567205013666160930113907 Lanza, 2018, Shiatsu as an adjuvant therapy for depression in patients with Alzheimer's disease: a pilot study, Compl Ther Med, 38, 74, 10.1016/j.ctim.2018.04.013 Zhao, 2017, Repetitive transcranial magnetic stimulation improves cognitive function of Alzheimer's disease patients, Oncotarget, 8, 33864, 10.18632/oncotarget.13060 Basar, 2004, Brain dynamics and memory, Int J Psychophysiol, 54, 7 Basar, 2004, Macrodynamics of electrical activity in the whole brain, Int J Bifurcat Chaos, 14, 363, 10.1142/S0218127404009284 Rossini, 2007, Clinical neurophysiology of aging brain: from normal aging to neurodegeneration, Prog Neurobiol, 83, 375, 10.1016/j.pneurobio.2007.07.010 Mantini, 2007, Electrophysiological signatures of resting state networks in the human brain, P Natl Acad Sci USA, 104, 13170, 10.1073/pnas.0700668104 Wang, 2002, Alteration of cortical EEG in mice carrying mutated human APP transgene, Brain Res, 943, 181, 10.1016/S0006-8993(02)02617-3 Pena-Ortega, 2013, Amyloid beta-protein and neural network dysfunction, Journal of neurodegenerative diseases, 2013, 657470, 10.1155/2013/657470 Pena-Ortega, 2012, Amyloid beta 1-42 inhibits entorhinal cortex activity in the beta-gamma range: role of GSK-3, Curr Alzheimer Res, 9, 857, 10.2174/156720512802455403 Dringenberg, 2000, Alzheimer's disease: more than a 'cholinergic disorder' - evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia, Behav Brain Res, 115, 235, 10.1016/S0166-4328(00)00261-8 Deal, 2017, Hearing impairment and incident dementia and cognitive decline in older adults: the health ABC study, J Gerontol a-Biol., 72, 703 Lin, 2011, Hearing loss and incident dementia, Arch Neurol-Chicago., 68, 214, 10.1001/archneurol.2010.362 Gong, 2011, Ginsenoside Rg1 protects primary cultured rat hippocampal neurons from cell apoptosis induced by beta beta-amyloid protein, Pharm Biol, 49, 501, 10.3109/13880209.2010.521514 Li, 2010, GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of alzheimer's disease, J Alzheimers Dis, 19, 1205, 10.3233/JAD-2010-1314 Hidisoglu, 2018, Alterations in spontaneous delta and gamma activity might provide clues to detect changes induced by amyloid- administration, Eur J Neurosci, 47, 1013, 10.1111/ejn.13832 Delorme, 2004, EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis, J Neurosci Methods, 134, 9, 10.1016/j.jneumeth.2003.10.009 Goodin, 1987, Electrophysiological differences between demented and nondemented patients with Parkinsons-disease, Ann Neurol, 21, 90, 10.1002/ana.410210116 Naatanen, 1987, The mismatch negativity to intensity changes in an auditory stimulus sequence, Electroencephalogr Clin Neurophysiol Suppl, 40, 125 Gurtubay, 2004, Gamma band responses to target and non-target auditory stimuli in humans, Neurosci Lett, 367, 6, 10.1016/j.neulet.2004.05.104 Yordanova, 1998, Event-related alpha oscillations are functionally associated with P300 during information processing, Neuroreport, 9, 3159, 10.1097/00001756-199810050-00007 Fries, 2007, The gamma cycle, Trends in neurosciences, 30, 309, 10.1016/j.tins.2007.05.005 Fries, 2009, Neuronal gamma-band synchronization as a fundamental process in cortical computation, Annu Rev Neurosci, 32, 209, 10.1146/annurev.neuro.051508.135603 Uhhaas, 2006, Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology, Neuron, 52, 155, 10.1016/j.neuron.2006.09.020 Grady, 2001, Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease, Brain: J Neurol, 124, 739, 10.1093/brain/124.4.739 Bokde, 2006, Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment, Brain: J Neurol, 129, 1113, 10.1093/brain/awl051 Iaccarino, 2016, Gamma frequency entrainment attenuates amyloid load and modifies microglia, Nature, 540, 230, 10.1038/nature20587 Belluscio, 2012, Cross-frequency phase-phase coupling between theta and gamma oscillations in the Hippocampus, J Neurosci, 32, 423, 10.1523/JNEUROSCI.4122-11.2012 Traub, 1999, On the mechanism of the gamma ->beta frequency shift in neuronal oscillations induced in rat hippocampal slices by tetanic stimulation, J Neurosci, 19, 1088, 10.1523/JNEUROSCI.19-03-01088.1999 Daulatzai, 2010, Early stages of pathogenesis in memory impairment during normal senescence and alzheimer's disease, J Alzheimers Dis, 20, 355, 10.3233/JAD-2010-1374 Shen, 2004, Brain cholinesterases: II. The molecular and cellular basis of Alzheimer's disease, Med Hypotheses, 63, 308, 10.1016/j.mehy.2004.02.031 Pennisi, 2011, Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability, J Neural Transm, 118, 587, 10.1007/s00702-010-0554-9 Alagona, 2004, Motor cortex excitability in Alzheimer's disease and in subcortical ischemic vascular dementia, Neurosci Lett, 362, 95, 10.1016/j.neulet.2004.03.006 Ferreri, 2003, Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation study, Ann Neurol, 53, 102, 10.1002/ana.10416 Pennisi, 2002, Motor cortex excitability in Alzheimer disease: one year follow-up study, Neurosci Lett, 329, 293, 10.1016/S0304-3940(02)00701-2